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Cytokinesis involves the formation of a cleavage fur-
row, followed by abscission, the cutting of the mid-
body channel, the final bridge between dividing cells.
Recently, themidbody ring became known as central
for abscission, but its regulation remains enigmatic.
Here, we identify BRUCE, a 528 kDa multifunctional
protein, which processes ubiquitin-conjugating ac-
tivity, as amajor regulator of abscission. During cyto-
kinesis, BRUCE moves from the vesicular system to
the midbody ring and serves as a platform for the
membrane delivery machinery and mitotic regula-
tors. Depletion of BRUCE in cell cultures causes
defective abscission and cytokinesis-associated
apoptosis, accompanied by a block of vesicular tar-
geting and defective formation of the midbody and
the midbody ring. Notably, ubiquitin relocalizes
frommidbody microtubules to the midbody ring dur-
ing cytokinesis, and depletion of BRUCE disrupts
this process. We propose that BRUCE coordinates
multiple steps required for abscission and that ubiq-
uitylation may be a crucial trigger.
INTRODUCTION
Cytokinesis is the concluding step of cell division by which the
prospective daughter cells separate their cytoplasmic volumes.
This process starts by contraction of a plasma-membrane-an-
chored actomyosin ring, leading to the formation of a cleavage
furrow (Eggert et al., 2006). By the end of furrowing, the dividing
cells are connected by a narrow, tubular intercellular bridge,
which contains the midbody consisting of tightly bundled anti-
parallel microtubules, which embrace a phase-dense circular
structure called midbody ring (or occasionally Flemming body).
At the final stage of cytokinesis, in a process termed abscission,
this bridge is cleaved, and two daughter cells are formed.
At themidbody, several cytokinesis-coupled events converge,
including degradation of cell cycle regulators, cytoskeleton rear-
rangements, membrane traffic, and plasmamembrane remodel-
ing. Recent reports demonstrate a direct involvement of the
traffic-regulating GTPases Arf1, Arf6 and Rab11 in cytokinesis832 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.(Albertson et al., 2005). Arf6 and Rab11 are coupled to the exo-
cyst complex, which seems crucial for the proper targeting of
vesicles to the site of abscission. Interestingly, some types of
vesicles seem to arrive at the midbody ring chiefly from only
one of the prospective daughter cells (Gromley et al., 2005), sug-
gesting an intrinsic asymmetric element in cytokinesis. The fac-
tors that control targeting to the midbody and guide midbody
ring assembly are largely unknown, but one protein required
for exocyst targeting to the midbody ring was recently identified
as centriolin, which also binds to the maternal centriole (Gromley
et al., 2003, 2005).
Previous studies revealed an emerging role of ubiquitylation
and proteasomal activity in regulating cytokinesis (Pines and
Lindon, 2005). Notably, ubiquitin-activating enzyme E1 and the
proteasome are concentrated on midbodies (Grenfell et al.,
1994; Wojcik et al., 1995), and both proteolytic and non-proteo-
lytic functions of ubiquitin seem to play a role. Chromosomal
passenger proteins, the kinase Aurora B and the baculovirus in-
hibitor of apoptosis repeat (BIR)-containing protein survivin, as
well as the Polo-like kinase Plk1 (Lindon and Pines, 2004) are
degraded just before or during cytokinesis (Lindon and Pines,
2004; Sumara et al., 2007). Proteasome inhibition after ana-
phase onset results in incomplete cytokinesis (Straight et al.,
2003), and, interestingly, combined inhibition of Cdk1 and pro-
teasomes can revert late cytokinesis to an apparent preana-
phase state (Potapova et al., 2006). A non-proteolytic role of
ubiquitin in cytokinesis is suggested by the fact that the ubiqui-
tin-controlled endosomal sorting complex required for transport
(ESCRT) is necessary for abscission (Carlton and Martin-Ser-
rano, 2007).
Proteins harboring a BIR domain (BIRPs) are primarily known
for their function to protect cells against apoptosis by their activ-
ity to inhibit caspases and proapoptotic factors through binding
and ubiquitin-dependent degradation (Verhagen et al., 2001).
However, BIRPs like survivin and cIAP1 are also crucial for cell
cycle events and cytokinesis (Li et al., 1999; Samuel et al.,
2005). Here, we report that another conserved BIRP, the 528
kDaprotein BRUCE (also known asApollon or BIRC6), is a crucial
regulator for the final stages of cytokinesis. BRUCE is a multi-
functional protein owing to the presence of different functional
domains and multiple binding partners (Bartke et al., 2004;
Hauser et al., 1998). Close to its amino (N)-terminus, BRUCE har-
bors a single BIR domain, which most closely resembles the BIR
of survivin. BRUCE can inhibit caspases through this domain,
Figure 1. BRUCE Shows a Cell Cycle-Dependent Localization
(A) BRUCE localizes to mitotic structures. Immunofluorescence (IF) of HeLa cells stained with anti-Plk-1 (red) and anti-BRUCE (green) and DAPI to visualize DNA.
The box outlined in yellow shows the enlarged midbody region of the cytokinesis merge. The scale bar represents 10 mm.
(B) BRUCE localizes to the midbody ring of U2OS cells. The midbody region is shown with anti-Aurora B (red) and anti-BRUCE (green) staining. The scale bar
represents 1 mm.
(C) Localization of BRUCE to the midbody ring depends on MKLP1. Top: lysates from siRNA-transfected HeLa cells were analyzed by BRUCE, MKLP1,
and a-tubulin immunoblotting. Bottom: midbodies of siRNA-treated cells are shown stained with anti-a-tubulin (red) and anti-BRUCE (green). The scale bar
represents 1 mm.
(D) BRUCE is found on midbody ring remnants. U2OS cells were stained with anti-BRUCE (green) and anti-golgin p230 (red), and DAPI (blue). The scale bar
represents 10 mm. The top z-stack on the left shows a midbody ring remnant in the plane of the plasma membrane (shown enlarged on the left).
(E) Relationship between BRUCE and constitutive secretory cargo. HeLa cells stably expressing HA-albumin are shown in different cell cycle stages with anti-HA
(green) and anti-BRUCE (red) staining. The scale bar represents 10 mm. The arrow shows the position of the midbody ring.and has antiapoptotic potential (Bartke et al., 2004). However, its
antiapoptotic function may be particularly relevant for the trans-
Golgi network (TGN) and vesicular structures where it mainly lo-
calizes (Hauser et al., 1998). Near its carboxy (C)-terminal end,
BRUCE carries a ubiquitin-conjugating (UBC) domain, which en-
dows the protein with a hybrid E2/E3 ubiquitin ligase activity
(Bartke et al., 2004; Hauser et al., 1998). In vitro, BRUCE primar-
ily mono- or oligo-ubiquitylates proteins, suggesting that itsmain
role is non-proteolytic (Bartke et al., 2004). BRUCE-knockout
mice usually die perinatally due to impaired placental develop-
ment that can be attributed to insufficient differentiation (Lotz
et al., 2004), and depletion of BRUCE in cultured cells sensitizes
against apoptotic stimuli and finally leads to cell death (Hao et al.,
2004; Ren et al., 2005).In this report we show that BRUCE is an important novel player
of cytokinesis and important for abscission. We demonstrate
that BRUCE localizes to the midbody ring during cytokinesis,
where it binds mitotic regulators and components of the vesicle
targeting machinery. Microscopic studies and live-cell imaging
with wild-type and BRUCE-depleted cells, and of cells that
express a dominant-negative version, revealed that BRUCE is
involved in the correct delivery of membrane vesicles to the site
of abscission and for the integrity of the midbody, in particular
the midbody ring. We further discovered a remarkable dynamic
relocalization of ubiquitin from the midbody to the midbody
ring, show that both BRUCE and MKLP1 are ubiquitylated and
that UBPY serves as their deubiquitylating enzyme. Our work
suggests that this giant protein, through its multiple activities,Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 833
Figure 2. BRUCE Is a Component of Tubular Endosomes, Interacts withMembrane Targeting Factors, and Contains aMidbody Ring-Target-
ing Domain
(A) BRUCE localizes to Rab8 tubular endosomes in interphase cells. U2OS cells stably expressing GFP-Rab8 (green) were fixed and stained with anti-BRUCE
(red) and DAPI (blue). The scale bar represents 10 mm.
(B) BRUCE colocalizes with the exocyst component Sec8 in a perinuclear compartment. Fixed U2OS cells; anti-BRUCE (red), anti-Sec8 (green). The scale bar
represents 15 mm.
(C) BRUCE copurifies with exocyst components Sec6, Sec8, and endosomal GTPases Rab8, Rab11. HEK293T cells were transfected with either FLAG-epitope
tagged luciferase or BRUCE. Cells were lysed and FLAG-fusion proteins purified. Bound material was eluted with FLAG peptide and analyzed by western
blots (WB).
(D) Colocalization of BRUCE with Rab11 recycling endosomes in cytokinesis. Fixed HeLa cells; anti-Rab11 (red), anti-BRUCE (green), and DAPI (blue). The scale
bar represents 15 mm.
(E) Rab8 tubular endosomes are found in the midbody region. Fixed U2OS cells; anti-tubulin (blue), and propidium iodide DNA staining (red). The scale bar
represents 10 mm.834 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.
crucially coordinates several events that conclude cytokinesis,
and additionally uncovers a previously unrecognized role of ubiq-
uitin in this process.
RESULTS
BRUCE Localizes to the Midbody Ring and Associates
with Mitotic Regulators
BRUCE is a cytosolic protein, which is peripherally associated
with endomembranes (Hauser et al., 1998). By using three differ-
ent polyclonal antibodies directed against N- or C-terminal re-
gions of BRUCE (Bartke et al., 2004; Hauser et al., 1998)
(Figure S1 available online) we found in both HeLa and U2OS
cells that BRUCE relocalizes considerably during the cell cycle.
It concentrates in a pericentriolar compartment in interphase,
moves partially to spindle poles in metaphase, and finally local-
izes to the spindle midzone and the midbody in telophase and
during cytokinesis (Figure 1A and Figure S2). On the midbody,
BRUCE localizes in a characteristic ring-like arrangement that
is embraced by Aurora B and microtubules (Figures 1B and
1C), indicating that BRUCE is associated with the midbody
ring (Gromley et al., 2005). By using siRNAs targeting MKLP1,
a mitotic kinesin essential for the formation of the midbody ma-
trix (Matuliene and Kuriyama, 2002), we observed in midbody
forming cells a complete loss of BRUCE at the midbody (Fig-
ure 1C). In untreated cells, BRUCE localized to the midbody ring
as soon as this structure first appeared in telophase, and BRUCE
persisted on the ring even after its uptake by one of the daughter
cells after completion of abscission (Figures 1D and 1E). To
investigate membrane traffic and to trace vesicles containing
constitutively secreted cargo, we constructed a HeLa cell line
expressing HA-epitope tagged albumin. Localization of secre-
tory vesicles on the midbody ring was visible only in late cytoki-
nesis when the intercellular bridge had constricted to about
1mm in diameter, whereas BRUCE, as an apparent firm resident
of the midbody ring, localized to the midbody ring much earlier,
concurrently when it had been formed (Figure 1E).
Given its highly dynamic localization pattern during cell divi-
sion, we searched for binding partners and asked whether
BRUCE might be a target for mitotic phosphorylation. Indeed,
we found that BRUCE was particularly phosphorylated in
S-phase extracts (data not shown) and that immunopurified
BRUCE was also phosphorylated by copurified factors
(Figure S3A). By immunopurification (IP) of FLAG-tagged
BRUCE, or immunoprecipitation of endogenous BRUCE, we
found BRUCE associated with the mitotic kinases Cdk1,
MEK1, and Plk-1 (Figures S3B–S3G) and also a-tubulin (datanot shown). Moreover, overexpressed BRUCE could immuno-
precipitate endogenous survivin, and vice versa, indicating that
these two BIRPs may cooperate at the midzone or the midbody,
where both proteins were found (Figures S3H and S3I).
BRUCE Is a Component of Tubular and Recycling
Endosomes and Associates with the Exocyst
To characterize BRUCE localization further, we assayed for co-
localization with markers of the vesicular system. We found
only partial colocalization with the TGN markers golgin p230
and TGN38 (Figure S2B and Hauser et al., 1998). However, we
observed substantial colocalization with GFP-tagged versions
of the endosomal GTPases Rab8 and Rab11, even with Rab8-
positive, peripheral tubular endosomes (Figure 2A and
Figure S4A) and with the exocyst subunit Sec8 (Figure 2B). Im-
portantly, Rab8 and Rab11, as well as the exocyst subunits
Sec6 and Sec8, physically associate with BRUCE, as demon-
strated by immunoprecipitations (Figure 2C and Figures S4B
and S4C). Similar to the mitotic kinases (Figure S3B), the binding
site for the exocyst seems to lie within the N-terminal region of
BRUCE (Figure S4D) and thus involves a different region in
BRUCE than for midbody ring interaction (see below). Notably,
similar to exocyst subunit Exo70 (Vega and Hsu, 2001), BRUCE
also relocalizes to growth cones in neuronally differentiated cells
(Figure S4E), strongly indicating that BRUCE is firmly connected
to the exocyst and plays a more general role in targeted mem-
brane delivery.
Rab11 and Rab8-Endosomes Are Sources of Membrane
Material in Cytokinesis and the Midbody Ring Acts
as a Barrier
Next, we asked whether vesicles containing BRUCE participate
in cytokinesis. We could confirm previous observations (Fielding
et al., 2005) that suggested a role for recycling Rab11-endo-
somes in cytokinesis. Two pools of Rab11-endosomes were
found on both sides of the intercellular bridge during cytokine-
sis, and a small fraction also seemed to reach the midbody
ring (Figure 2D). However, in contrast to a recent report on
HeLa cells (Yu et al., 2007), we found in engineered U2OS cells
also GFP-Rab8 staining at the midbody (Figures 2E and 2F) and
also at the newly formed plasma membrane at the contact site
of dividing cells (Figure 2G). Indeed, live-cell imaging suggests
that Rab8-endosomes are delivered to the midbody ring and
that this supplied material then diffuses at the plasma mem-
brane laterally (data not shown). Remarkably, by using photo-
bleaching experiments, we found that Rab8-endosomes are un-
able to move freely from one perspective daughter cell to the(F and G) Rab8 is found at the midbody ring and at the newly formed plasmamembrane between dividing cells. Fixed U2OS cells; arrowheads indicate the site of
the newly formed plasma membrane. The scale bars represent, respectively, (F) 10 mm and (G) 2 mm. The smaller figures are enlargements of the framed areas.
The position of the midbody ring is indicated by an arrow.
(H) The C terminus of BRUCE represents a midbody ring-targeting domain. GFP fused to the C terminus of BRUCE (amino acids 4711–4845, GFP-BRUCE-C) is
localized to the midbody ring. The movie stills (of Movie S5) show GFP-BRUCE-C on the midbody ring of HeLa cells. The scale bar represents 15 mm.
(I) Localization of BRUCE-C relative to centrosomes. HeLa cells transfected with GFP-BRUCE-C (green) were stained with anti-g-tubulin (red). The image shows
a merge with the bright-field channel. The scale bar represents 15 mm.
(J) The midbody ring-targeting domain of BRUCE interacts with MKLP1. Top: lysates of HEK293T cells were immunoprecipitated (IP) with either rabbit IgGs or
anti-MKLP1 antibodies and analyzed by anti-BRUCE WB. Middle: HEK293T cells transfected with GFP-FLAG-BRUCE-C were lysed and proteins immunopre-
cipitated with rabbit IgG (control) or anti-MKLP1 IgGs. Input and precipitates (IP) were analyzed by anti-FLAG blots (WB) detecting BRUCE-C. Bottom: HEK293T
cells were either transfected with empty vector or GFP-FLAG-BRUCE-C. Lysates were subjected to anti-FLAG IP and analyzed by anti-MKLP1 WB.Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 835
Figure 3. BRUCE Depletion Causes Cytokinesis Defects and Cytokinesis-Associated Apoptosis
(A) BRUCE depletion in U2OS cells has only minor consequences for p53 levels. Lysates of cells transfected with the indicated siRNAs were analyzed by western
blots with the indicated antibodies.
(B) BRUCE depletion in U2OS cells induces syncytia-like structures. Cells were treatedwith siRNAs for 3 days as shown in Figure 1C targeting lamin A/C, survivin,
or BRUCE. After 3 days of incubation, a representative area of cells was photographed (scale bar represents 20 mm), cells were harvested and prepared for
propidium iodide staining, and the DNA content of cells was analyzed by flow cytometry. The 4N peak is marked by an arrow.
(C) Cell cycle distribution after treatment with increasing concentrations of siRNA. Cells were treated with siRNA as in (A). The graph represents the cell cycle
distribution as obtained by flow cytometry of the DNA content.
(D) Defective cytokinesis after BRUCE depletion. siRNA-treated U2OS cells were observed by differential interference contrast (DIC) microscopy. The images
represent stills of movies at representative time points. The scale bar represents 20 mm.
(E) HeLa cells depleted of BRUCE undergo cytokinesis-associated apoptosis. HeLa cells were treated with siRNAs for 2 days as in (A), fixed, and stained with
anti-MKLP1 (green) and anti-a-tubulin (red). The scale bar represents 15 mm.
(F) Quantification of (E) with apoptotic cells relative to total cells and apoptotic cytokinesis versus total cells in cytokinesis (error bars represent ± SD of two
independent experiments).836 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.
other once the midbody ring has been assembled in telophase
(Movies S1 and S2), which differs from the otherwise mobile be-
havior of these vesicles during interphase. This finding consider-
ably substantiates the idea that midbody rings, in addition to
acting as the site for membrane delivery, may play a role as a dif-
fusion barrier in-between the two prospective daughter cells
(Schmidt and Nichols, 2004). Apparently, this barrier does not
only prevent intercellular exchange of plasma membrane-asso-
ciated material as shown before (Schmidt and Nichols, 2004),
but also of endosomal vesicles.
BRUCE Harbors a Midbody Ring-Targeting Domain
The distinctive and dynamic localization of BRUCE suggested
the presence of dedicated targeting domains. By using trunca-
tion constructs we in fact noticed that the typical localization of
BRUCE at sorting compartments requires its C-terminal region
(Figure S4F). Surprisingly, when we constructed a GFP-fusion
of the C-terminal 145 amino acids of BRUCE (termed BRUCE-
C), this construct localized exclusively to the midbody ring (Fig-
ures 2H and 2I and Movie S3 and S4). Time-lapse video micros-
copy revealed that the BRUCE-C-labeled ring-like structure
showed a degree of mobility and tilting characteristic for themid-
body ring, and that it was taken up by one of the daughter cells
after abscission (Figure 2H and Movie S5). As the localization of
endogenous BRUCE to the midbody ring depends on MKLP1
(Figure 1C), we speculated that BRUCE-C might contain a spe-
cific interaction domain with midbody ring components. Indeed,
we found MKLP1 coprecipitating with full-length, endogenous
BRUCE (Figure 2J, top panel) and also with BRUCE-C
(Figure 2J, middle panel). Interestingly, BRUCE-C selectively
bound the faster migrating variant, MKLP1, but not CHO1,
a larger variant caused by alternative splicing that additionally
possesses an actin-interacting tail (Figure 2J, lower panel). As
both isoforms are present at the midbody (Kuriyama et al.,
2002), this finding argues for different functions of these two var-
iants during late stages of cytokinesis. Notably, the C-terminal
tail of BRUCE (BRUCE-C) is highly conserved from flies to verte-
brates, suggesting that the identified midbody ring-targeting do-
main (MTD) and the interaction with MKLP1 are features of all
BRUCE family members.
BRUCE Depletion Causes Defective Abscission
and Cytokinesis-Associated Apoptosis
Depleting BRUCE from cultured cells was previously shown to
reduce cell viability (Ren et al., 2005). To identify the basis of
this phenotype, we designed different siRNAs targeting BRUCE
(see Supplemental Experimental Procedures and Figure S5).
Delivery of BRUCE-targeted siRNA by electroporation in U2OS
cells depleted BRUCE to undetectable levels 3 days after trans-
fection (Figure 3A). These cells acquired a striking elongated
appearance and built up interconnected cells, but in contrast
to survivin depletion, no cells with giant nuclei developed
(Figure 3B and Figure S1C). Moreover, reminiscent of centriolin
depletion (Gromley et al., 2003), some apparently not com-
pletely detached cells fused again together or underwent mito-sis (data not shown and see below). Higher siRNA concentra-
tions and longer incubation times resulted in a decrease in the
amount of normal G1 phase (2N) cells (Figure 3C and data not
shown) but a strong rise of a sub-G1 population, indicative of
syncytia-like cells, which finally undergo apoptosis. However,
different from the results by Ren and coworkers (Ren et al.,
2005), no rise in the levels of p53 or of p53 targets like p21
were observed (Figure 3A), suggesting that apoptosis in these
cells is not an immediate response to BRUCE depletion but
a later corollary. Live-cell video microscopy showed that
BRUCE-depleted cells form a normal cleavage furrow, but do
not complete cytokinesis even after hours, and that some
cells even did not regain their normal flattened appearance
(Figure 3D). When we depleted BRUCE in HeLa cells, cells
underwent apoptosis, but, intriguingly, only during attempted
cytokinesis (Figures 3E–3G). After the formation of the midbody
ring, almost 60% of the cells were apoptotic (Figure 3F), and
membrane blebbing occurred already 30 min after furrowing
(Figure 3G). This suggests a mechanism by which apoptosis is
triggered by cues that originate at the midbody in the absence
of BRUCE.
BRUCE Is Involved in Membrane Delivery
to the Midbody Ring
Because BRUCE-C binds to the midbody ring so well, we won-
dered whether we could utilize it as a dominant-negative tool
specifically to monitor the function of BRUCE at this location. In-
deed, overexpression of BRUCE-C could displace endogenous
BRUCE fromMKLP1 and the midbody ring (Figure 4A) and led to
aberrant cytokinesis and binucleation (Figures 4B and 4C). Nota-
bly, after prolonged expression of BRUCE-C for 3 days, apopto-
sis occurred (Figure S6), indicating that the apoptotic signal is in
fact triggered by the absence of BRUCE from the midbody ring.
When we analyzed HeLa cells that stably express tagged albu-
min, we found secretory vesicles within the intercellular bridge.
Intriguingly, however, cells overexpressing BRUCE-C showed
single balloon-like accumulations of cargo-containing vesicles
in close proximity to the intercellular bridge, but only on one of
its sides (Figure 4B). From these findings we conclude that the
presence of BRUCE at themidbody is needed for normal delivery
of vesicles to the site of abscission and that prolonged absence
of BRUCE interferes with cytokinesis.
To corroborate BRUCE’s role in vesicle traffic, we next ad-
dressed in U2OS cells that stably express GFP-Rab11 whether
also siRNA-directed BRUCE depletion interferes with normal
membrane targeting. When we examined control cells (trans-
fected with a control siRNA) that had just completed cytokinesis
(Figure 4D, upper panel), Rab11 had already adopted typical in-
terphase localization and phosphotyrosine was found on the
midbody as reported (Kasahara et al., 2007). In striking contrast,
BRUCE-depleted cells accumulated Rab11-endosomes, as well
as phosphotyrosine-positive material, in close proximity to one
side of the midbody (Figure 4D, lower panel). This finding con-
firms our conclusion that BRUCE is needed for the targeting of
vesicles to the midbody, and further suggests that BRUCE is(G) Stills with DIC live-cell microscopy of HeLa cells treated with lamin siRNA (top) or BRUCE siRNA (bottom) for 2 days. Note that cells depleted for BRUCE
undergo apoptosis after attempted cytokinesis. The scale bar represents 15 mm.Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 837
Figure 4. BRUCE Functions in Membrane Delivery to the Midbody Ring
(A) Exogenously expressed BRUCE fragment containing the midbody ring-targeting domain competes with endogenous BRUCE for midbody ring binding via
MKLP1. HEK293T cells were transfected with increasing amounts of GFP-BRUCE-C and decreasing amounts of GFP. Lysates (inputs are shown in the left panel)
were subjected to immunoprecipitation (IP) with rabbit IgGs (control) or anti-MKLP-1 antibodies, and precipitated proteins were analyzed by western blots. Com-
petition on the single-cell level is shown for HeLa cells by immunofluorescence (endogenous, full-length BRUCE, red; GFP-BRUCE-C, green; DNA stained with
DAPI). The arrowhead marks the midbody ring. The scale bar represents 10 mm.
(B) Expression of BRUCE-C leads to secretory vesicle accumulation in close vicinity to the midbody ring. Top: enlarged midbody region of a HeLa cell stably
expressing albumin (green; cells as in Figure 1E) and stained for endogenous BRUCE (red). Bottom: similar to above, but cells were transfected with GFP-
BRUCE-C (green), fixed, and stained. A representative cell in cytokinesis is shown with the enlarged midbody region on the right. The scale bar represents
10 mm; scale bar of clippings represents 2 mm.838 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.
crucial for the presence of tyrosine kinases at the midbody as
well. Both functions might be linked, however, as sorting of Src
and ERK to the midbody seems to depend on Rab11 (Kasahara
et al., 2007).
Midbodies and Midbody Rings Are Platforms
for Ubiquitylation
Since BRUCE possesses ubiquitin ligase activity (Bartke et al.,
2004; Hauser et al., 1998), we next asked whether the midbody
ring might be a site of ubiquitylation. Contrary to the current be-
lief (Pines and Lindon, 2005), we could observe a dramatic reloc-
alization of ubiquitin during cytokinesis (Figure 5A and Movie S6)
using a cell line that stably expresses a GFP-ubiquitin fusion pro-
tein that can form conjugates in vivo (Dantuma et al., 2006). Par-
allel to the formation of the midbody ring in late telophase, ubiq-
uitin is first concentrated onmidzonemicrotubules but not on the
midbody ring. However, once the microtubules start to constrict
to form the midbody, the bulk of ubiquitin vanishes rapidly from
this area, but after a brief period of absence, reappears concen-
trated on the midbody ring.
Motivated by this so far unrecognized behavior of ubiquitin, we
performed fluorescent recovery after photobleaching (FRAP)
experiments with U2OS cells to address the dynamics of this
unusual process. In contrast to normal ubiquitin pools in the
same cell in the cytosol or on midbody microtubules, ubiquitin
on the midbody ring during cytokinesis showed a vastly reduced
recovery (Figure 5B, left panels). Moreover, also midbody rings
that had already been taken up by one daughter after completed
cytokinesis showed virtually no recovery (Figure 5B, right
panels). This suggests that ubiquitin has a high turnover at the
midbody through active ubiquitylation and deubiquitylation of
proteins near the midbody microtubules. In striking contrast,
ubiquitin on midbody ring components, once this modification
had occurred, can barely be replaced, suggesting that the local
ubiquitylation activity is turned off at this stage. Notably, BRUCE
and ubiquitin are closely associated during cell division and co-
localize at the midbody ring during late cytokinesis (Figure 5C),
suggesting that at least some of the detected ubiquitylation
may be mediated by BRUCE (see Discussion).
Relocalization of ubiquitin during cytokinesis was similar in
HeLa cells (Figure 5D, top panel), and cells of both cell lines often
harbored besides the midbody ring engaged in cytokinesis one
or rarely two additional rings, which most likely represent rem-
nants from previous divisions. Intriguingly, only the putative ac-
tive midbody ring in the intercellular bridge was decorated with
ubiquitin whereas the midbody ring remnants had apparently
gradually lost the modification (Figure 5D, lower panel). This
finding is in agreement with our FRAP data (Figure 5B), showing
that ubiquitylation of the midbody ring occurs only once during
cytokinesis, before the onset of abscission.
BRUCE is known to homooligomerize (Bartke et al., 2004) and
seems to associate in part with the deubiquitylating enzymeUBPY (alias USP8) and the RING-finger ubiquitin ligase Nrdp1
(alias FLRF) (Wu et al., 2004). We therefore askedwhether deubi-
quitylating activitymight influencemidbody localized ubiquitin as
well. By using a catalytically inactive form of UBPY (UBPYC > A)
that serves as a substrate trap (Alwan and van Leeuwen, 2007),
we observed that it bound both BRUCE and MKLP1 (Figure 5E).
Intriguingly, also UBPYC > A localizes to the midbody ring
(Figure S7), suggesting that ubiquitylation and deubiquitylation
activitiesmay perhapswork as a switchboard at this site. BRUCE
itself is ubiquitylated at its C-terminal domain (data not shown)
and this modification is enhanced upon Nrdp1 overexpression,
and conversely lost when UBPY is overexpressed (Figure 5F).
Using a denaturing purification protocol that preserves ubiquitin
modifications we also found that MKLP1 is modified by mono-/
oligo- but not poly-ubiquitylation, and that this modification is
strongly reduced if UBPY was overexpressed (Figure 5G). While
BRUCE overexpression triggered no increase in MKLP1 ubiqui-
tylation (data not shown), overexpression of the dominant-nega-
tive UBPYC > A version induced this modification (Figure 5G),
suggesting that another ubiquitin ligase acts on MKLP1, or that
deubiquitylation rather than ubiquitylation activity might be
limiting and important for regulation. In fact, more than 30% of
HeLa cells transfected with UBPYC > A exhibited cytokinesis
defects linked with binucleation and mislocalized MKLP1 from
its normal interphase localization in the nucleus to the cytoplasm
(Figure 5H). This phenotype is reminiscent of an MKLP1 knock-
down, suggesting that perhaps UBPY-mediated deubiquitylation
of MKLP1 may trigger nuclear import, which appears to be
needed for normal cytokinesis (Liu and Erikson, 2007).
BRUCE Is Crucial for Midbody Integrity,
Midbody Ring Formation, and Midbody-Localized
Ubiquitin
Prompted by the striking physical and functional connection of
BRUCE with the midbody and the midbody ring, we next asked
whether BRUCE itself is crucial for the organization of these
structures. Indeed, we observed significantly reduced MKLP1-
positive midbody material in BRUCE-depleted cells (Figure 6A
and see also Figure 4D). Additionally, we detected a gradual
effect on the midbody structure upon continued BRUCE deple-
tion. Depletion for no more than three days led to moderately
misorganized midbodies with unfocused Aurora B staining
(Figure 6B, top panel) and unconstricted microtubules
(Figure 6C, top panel). However, BRUCE depletion for five
days resulted in syncytia-like cells, which contained severely
malformed midbodies, as visualized by Aurora B or MKLP1
staining (Figures 6B and 6C lower panels). In the end, most cells
failed to form their midbody rings altogether and no remnants
persisted, and those few cells that retained their midbody rings
(less than 10%), had hitherto not adopted a syncytia-like appear-
ance (Figures 6D and 6E). We also explored whether BRUCE
depletion affects the distribution of ubiquitin at the midbody.(C) Prolonged expression of BRUCE-C leads to binucleation and apoptosis. HeLa cells were transfected either with GFP or GFP-BRUCE-C, stained with propi-
dium iodide 1 and 3 days after transfection and DNA content was analyzed by flow cytometry gating for transfected cells.
(D) Recycling endosomes accumulate close to the midbody ring in BRUCE-depleted cells. U2OS cells stably expressing GFP-Rab11 (green) were treated with
siRNAs as in Figure 1C fixed and stained for MKLP1 (blue) and phosphotyrosine (pY, red) with enlarged views of the midbody ring on the right. The scale bar
represents 15 mm; scale bar of clippings represents 1 mm.Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 839
Figure 5. Ubiquitylation on the Midbody Ring
(A) Ubiquitin (Ub) is concentrated on midbody microtubules and reappears on the midbody ring after midbody constriction. U2OS cells stably expressing GFP-
tagged ubiquitin (GFP-Ub) were analyzed by time-lapse video microscopy. A representative cell is shown with the movie stills (of Movie S6) starting in prome-
taphase and ending shortly before abscission. The scale bar represents 20 mm.
(B) Ubiquitin at the midbody ring shows almost no exchange with the cellular ubiquitin pool. U2OS cells as in (A) were used for FRAP experiments. Left: a cell with
ubiquitin on themidbody ringwas bleached in the cytoplasm or at themidbody ring. The recovery of the fluorescence signal is shown on the right. Right: a cell with
a midbody ring remnant in the plane of the plasma membrane was either bleached in the cytoplasm or at the midbody ring remnant. Only fluorescence recovery
curves are shown. The scale bar represents 20 mm.
(C) Association of BRUCE with ubiquitin at the midbody ring. U2OS cells were transiently transfected with HA-epitope tagged ubiquitin (HA-Ub, red). Cells were
fixed and stained with anti-BRUCE (green) and DAPI (blue). The scale bar represents 10 mm. The framed areas are shown enlarged.840 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.
Indeed, in contrast to cells treated with a control siRNA
(Figure 6F, upper panel, and Movie S7), cells depleted for
BRUCE neither showed a distinct ubiquitin staining at midbody
microtubules nor at the survivingmidbody rings (Figure 6F, lower
panel and Movie S8). These results suggest that BRUCE is not
only crucial for normal vesicle targeting to the site of abscission,
but also for the integrity of the midbody and the midbody ring,
and its striking ubiquitin modification.
DISCUSSION
The two most perceptible processes of cytokinesis of animal
cells, the contraction of the cleavage furrow and the physical
separation of the daughter cells by abscission, are now recog-
nized as two functionally and mechanistically different steps.
Central to abscission is the midbody, which is the target site
for membrane delivery and membrane fusion, the driving forces
of abscission. In particular the unique midbody ring, located at
the midpoint of the intercellular bridge, has drawn attention re-
cently as it seems to be the key structural element that guides
the events that lead to abscission. This rigid and unvaryingly
sized structure, originally described by Flemming as ‘‘Zentral-
ko¨rper’’ (Flemming, 1891), thus sometimes called ‘‘Flemming
body,’’ materializes in telophase and survives in one daughter
cell often until the next division.
In this report, we identified BRUCE as a constant companion
of the midbody ring and found that its normal assembly requires
BRUCE. Moreover, we found that BRUCE is crucial for mem-
brane delivery to the cleavage site and for normal abscission.
Membrane Dynamics
Recent studies have emphasized the decisive role of plasma
membrane reorganization during abscission (Albertson et al.,
2005). This process requires vesicle-mediated transport and
the incorporation of additional membrane to the site of abscis-
sion by hetero- and homotypic membrane fusion events. As
shown previously for (Rab11-positive) recycling endosomes,
our data suggest that also (Rab8-positive) tubular endosomes
significantly contribute to membrane dynamics during cytokine-
sis (Figure 2G). Previous studies suggested that membrane de-
livery to the midbody occurs largely asymmetric, i.e., only from
one of the prospective daughter cells. However, when we mon-
itored cargo delivery or endosomal sorting in unperturbed U2OS
cells (which may require more membrane reshaping than HeLacells) we failed to detect any marked asymmetry of membrane
delivery to the intercellular bridge. However, upon interfering
with BRUCE function by either BRUCE depletion or overexpres-
sion of the dominant-negative BRUCE-C variant (that does not
bind the exocyst or Rab8/11 GTPases) cells strikingly accumu-
lated large vesicular structures close to only one side of the mid-
body ring. Thus abscission has indeed an intrinsic asymmetric
contribution, and BRUCE appears to be crucial for normal vesi-
cle targeting. In fact, BRUCE seemswell equipped to function as
a midbody targeting factor for vesicles as it binds via its N-termi-
nal region to the exocyst and endosomal components and via its
C-terminal targeting domain to the midbody ring.
BRUCE and the Midbody Ring
Our studies suggest an intimate relationship between BRUCE
and the midbody ring. In interphase cells, BRUCE localizes to
the TGN and endosomes, but during cytokinesis, a fraction
moves to themidzonewhere it specifically arrives at themidbody
ring. Notably, BRUCE associates with themidbody ring concom-
itantly with its appearance in telophase, travels after completed
abscission with the midbody ring into one daughter cell, and re-
mains bound to the discarded midbody ring all along until a new
ring is formed during the next cell division (Figure 1A and 5D).
Most importantly, BRUCE depletion prevents normal midbody
ring formation, suggesting that its activity may indeed be re-
quired for proper ring assembly.
The midbody ring appears to mediate at least two functions.
First, it seems to play a role as the docking site for vesicles,
which supply the plasma membrane with new material at the
site of abscission. As detailed above, BRUCE is crucial for this
process. Second, perhaps similar to the septin ring of yeast
(Faty et al., 2002), the midbody ring seems to function as a diffu-
sion barrier. Previous studies indicated that the midbody ring
prevents plasma membrane diffusion across the intercellular
bridge (Schmidt and Nichols, 2004). Our FRAP experiments ex-
tend these findings as they indicate that also Rab8-endosomes
are unable to transverse the ring from one prospective daughter
cell to the other. Therefore, the midbody ring may represent the
first physical barrier that disunites the daughter cells. As ob-
served before (Gromley et al., 2005), perhaps fueled by asym-
metric membrane delivery, the midbody ring is pushed to one
daughter cell where it is eventually dissolved. As BRUCE follows
the same path, even the final fate of the midbody ring appears to
be allied with BRUCE.(D) Ubiquitin is lost from midbody ring remnants when cells acquired an active midbody ring. HeLa cells were transfected with GFP-Ub (green). Top panels show
fixed cells in telophasewith anti-MKLP1 staining (red). Lower panels show a cell in late cytokinesis with a putative active midbody ring and a remnant, both lying in
the intercellular bridge. Note that the midbody ring remnant (open arrowhead) is not labeled with ubiquitin. The scale bar represents 10 mmand 2 mm (for enlarged
areas).
(E) Both BRUCE and MKLP1 interact with UBPY. HEK293T cells were transfected with empty vector or FLAG-epitope tagged UBPY and its catalytically inactive
mutant (C > A). Cells were lysed and proteins were immunoprecipitated (IP) with anti-FLAG and analyzed by western blots (WB).
(F) BRUCE is deubiquitylated by UBPY. HEK293T cells were transfected with empty vector and HA-tagged ubiquitin (HAUb) in combination with FLAG-tagged
UBPY wild-type and mutant proteins (FLAGUBPY, FLAGUBPY(C > A)) and FLAG-tagged Nrdp1 (FLAGNrdp1). Lysates were prepared and subjected to anti-HA
immunoprecipitation, and both lysates (Input) and immunoprecipitated material (IP) were analyzed by western blots (WB).
(G) MKLP1 is ubiquitylated in cells and is deubiquitylated by UBPY. HEK293T cells were transfected with HAUb or His6-epitope tagged ubiquitin (His6-Ub) in
combination with FLAGUBPY and FLAGUBPY(C > A). Lysates were subjected to denaturing Ni-NTA pull down and analyzed by western blots (WB).
(H) Overexpression of catalytically inactive UBPY leads toMKLP1mislocalization and binucleation of cells. HeLa cells were transfected with empty vector (mock)
or FLAGUBPY(C > A). Left: cells were fixed and stained with anti-MKLP1 (green) and anti-FLAG (red) antibodies. The open arrowhead marks a transfected cell. The
scale bar represents 15 mm. Right: quantification of binucleate versus total cells (two independent experiments labeled #1 and #2, respectively).Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 841
Figure 6. BRUCE Depletion Causes Structural Aberrations of the Midbody and Ubiquitin Mislocalization
(A) Reduced midbody material after BRUCE depletion as revealed by MKLP1 staining. U2OS cells were treated with siRNAs targeting lamin A/C or BRUCE as in
Figure 1B. After 3 days, cells were fixed and stained with anti-a-tubulin (green) or anti-MKLP1 (red) antibodies. The scale bar represents 15 mm.
(B) Misorganization and rupture of the midbody after BRUCE depletion. U2OS cells were treated with siRNAs as in (A). Cells were fixed after 3 days and stained
with anti-Aurora B (green) antibodies and DAPI. Top: BRUCE-depleted cells that have hitherto not acquired an elongated appearance exhibit aberrant midbodies
(shown enlarged in insets) (scale bary 15 mm). Bottom: BRUCE-depleted cells that resemble syncytia contain fragmented Aurora B-positive material. The scale
bar represents 20 mm.
(C) Midbody ring rupture in BRUCE-depleted cells as indicated by MKLP1 localization. The experiment was performed as in (B), and cells were fixed either after
3 or 5 days, stained for MKLP1 (green), a-tubulin (red), or DNA with DAPI (blue). After 5 days of siRNA treatment, syncytial cells arose with aberrant midbody rings
(arrowheads). The scale bar represents 10 mm.
(D) Growth retardation and loss of midbody rings after BRUCE depletion. Experiment was performed as in (B); cells were fixed after 5 days and stained with anti-
MKLP1 (green) and DAPI. Arrowheads point to MKLP1-stained midbody rings.
(E) Quantification of (D). The scale bar represents 30 mm.
(F) Concentration of ubiquitin at the midbody is lost in BRUCE-depleted cells. U2OS cells stably expressing GFP-Ub (see Figure 5A) were analyzed by time-lapse
video microscopy. Stills are from Movie S8. The scale bar represents 15 mm.BRUCE Is Crucial for Faithful Cell Division
A further consequence of BRUCE depletion is the appearance of
syncytial cells and sometimes a reunion followed by mitosis of
apparently incompletely separated cells (Movie S8). Syncytial
cells also form upon centriolin depletion (Gromley et al., 2005),
suggesting that perhaps BRUCE and centriolin, a protein of un-842 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.known biochemical activity, fulfill related or coupled functions in
cytokinesis. Although BRUCE/ embryos survive embryogene-
sis and usually die only shortly before birth, we also noticed a
delay in cell cycle progression of mouse embryonic fibroblasts
(MEFs) isolated from BRUCE/ embryos (Lotz et al., 2004)
and aberrant divisions characterized by multipolar spindles
and tripolar cytokinesis in spontaneously immortalizedBRUCE/
MEFs (unpublished data). This suggests that cells may adapt to
a loss of BRUCE activity, however, with the predisposition (per-
haps depending on the cell type) of erroneous cell divisions. In-
triguingly, BRUCE depletion in HeLa cells induces apoptosis
precisely at the time of attempted abscission (Figure 3G). Since
we also observed apoptosis upon prolonged expression of
BRUCE-C, which displaces endogenous BRUCE from the mid-
body ring (Figure S6D), the apoptotic cue seems to materialize
specifically when BRUCE is absent from this structure. As
BRUCE possesses antiapoptotic activity and binds caspases
(Bartke et al., 2004), it seems reasonable to assume that the ob-
served cell death may be a direct consequence of the lack of
BRUCE activity at the midbody ring. Notably, BRUCE also phys-
ically associates with survivin, which also localizes to the mid-
body, and BRUCE is able to ubiquitylate this BIRP in vitro
(Figure S3 and data not shown). It thus seems attractive to spec-
ulate that perhaps BRUCE and survivin normally collaborate, and
that BRUCE depletion alters the local antiapoptotic activity with
possible consequences for caspase activation (O’Connor et al.,
2000).
Ubiquitin Dynamics During Cytokinesis
In this studywe discovered a unique and highly dynamic localiza-
tion pattern of ubiquitin conjugates at themidbody during cytoki-
nesis. At the time when the actomyosin ring has maximally con-
stricted, ubiquitin is unusually concentrated in two large foci
symmetrically localized near both plus-end tips of midbody mi-
crotubules (Figure 5A). This almost compartmentalized compac-
tion may be indicative of a concentration of ubiquitylation/deubi-
quitylation activities and extensive protein turnover at these sites.
It seems attractive to speculate that substrates may include mi-
totic regulators or components of the vesicular sorting machin-
ery. Strikingly, in the succeeding 15–30min interval, ubiquitin dis-
appeared from the midbody to undetectable levels, but
reappears firmly associatedwith themidbody ring.Ubiquitylation
of the midbody ring seems to occur only once during cytokinesis
and appears to be stable until abscission is completed, as indi-
cated by our photobleaching experiments. Furthermore, this
modification appears to be largely mono-ubiquitin as indicated
by the fact that conjugates of GFP-ubiquitin, in which the ubiqui-
tin domain lacks lysine residues (GFP-ubiquitin-K0), enriched
normally at the midbody ring but not at the midbody flanks
(Figure S8). Together these data suggest that midbody ring
(mono) ubiquitylationmay serve structural or regulatory functions
rather than promoting proteasomal proteolysis.
As BRUCE is tightly connected to the midbody ring and re-
quired for its integrity, it seems reasonable to speculate that its
ubiquitin ligase activity may contribute to these ubiquitylation
events. However, ubiquitylation is also required for protein sort-
ing via the ESCRT pathway, which plays a role in cytokinesis
(Carlton and Martin-Serrano, 2007; Morita et al., 2007). In fact,
the BRUCE-associated deubiquitylating enzyme UBPY harbors
a so-called MIT-domain that mediates association with proteins
of the ESCRTIII complex (Row et al., 2007). Moreover, disassem-
bly of the ESCRTIII complex is thought to be catalyzed by Vps4,
an AAA-ATPase that seems to play a crucial role at late stages of
cytokinesis (Morita et al., 2007). Whatever the crucial ubiquityla-tion targets are, the unique combination of multiple activities in
a single large protein suggests that BRUCE may coordinate cy-
tokinesis events perhaps in a stepwise fashion. Strikingly, after
completed cytokinesis, midbody ring-localized BRUCE is dis-
carded into only one of the two daughter cells as well, possibly




Cloning of BRUCE and engineering of mutants and truncations was described
previously (Bartke et al., 2004; Hauser et al., 1998). BRUCE cDNAs were ex-
pressed from pCI (Promega) or pCMV2 vectors (Stratagene) as was FLAG-
tagged cDNA of luciferase. GFP-BRUCE-C (amino acids 4711–4845) was
cloned into pEGFP-CI (Clontech) using an internal XhoI site (bp 14135).
Nrdp1 was amplified from HeLa mRNA using primers that generate an N-ter-
minal FLAG-epitope tag and cloned into pCI. GFP-Rab8 was a gift of J. Pera¨-
nen, GFP-Rab11 was obtained fromM. Zerial, GFP-ubiquitin and GFP-ubiqui-
tin-K0 were gifts of N. Dantuma, HA-epitope-tagged rat albumin was a gift of
D. LeBel and FLAG-epitope-tagged UBPY and its mutant were from H. Alwan.
Antibodies
A detailed list of antibodies can be found in the Supplemental Experimental
Procedures.
Cell Culture and Transfections
U2OS, HeLa, and HEK293T cells were maintained at 37C, 7.5% CO2 in
DMEM (SIGMA) supplemented with 10% FCS. Transient transfections were
performed in 10 cm dishes (293T) or 6-well plates (HeLa) using calcium phos-
phate or lipofection protocols, as described previously (Bartke et al., 2004).
U2OS cells were transfected by electroporation using AMAXA Nucleofector
kit according to the manufacturer’s recommendations. siRNA duplexes
were obtained from MWG and were transfected at a final concentration of
100 nM. siRNA sequences are listed in supplemental material and methods.
HeLa cells stably expressing HA-rAlb and U2OS cells stably expressing
GFP-Rab8, GFP-Rab11 and GFP-ubiquitin were generated by selecting cells
with 750 mg/ml G418 (SIGMA) after lipofection for 3–4 weeks.
Flow Cytometry
DNA histograms were obtained by flow cytometry of PI-stained ethanol-fixed
cells using standard protocols, a FACSCalibur system and CELLQuest analy-
sis software (Becton Dickinson).
Coimmunoprecipitations and Immunoblot Analysis
Immunoprecipitations, purification of FLAG-fusion proteins, and immunoblot
analysis were carried out as described previously (Bartke et al., 2004).
Denaturating Ni-NTA Pull-Down
Transiently transfected HEK293T cells were harvested and pellets were
washed once in PBS. Cells were lysed in 6 M guanidine-HCl, 0.1M NaH2PO4,
0.1% Tween-20, 0.01M Tris (pH 8.0). Lysates were briefly sonicated to shear
DNA. An aliquot of the lysate was kept for TCA precipitation. The remaining ly-
sate was incubated with Ni-NTA agarose beads (QIAGEN) for 3–5 hr. Beads
were washed 5 times with 8 M urea, 0.1 M NaH2PO4, 0,1% Tween-20,
0.01M Tris (pH 8.0), and twice with PBS, 0.01% Tween-20. TCA precipitates
and beads were boiled in loading buffer and subjected to SDS-PAGE and
immunoblotting.
Immunofluorescence and Live-Cell Microscopy
Immunofluorescence was performed according to standard protocols after
fixation in methanol (20C, 3 min). Images were acquired on a Leica DM
RXAmicroscope equipped with a Hamatsu ORCA-ER camera. Image acquisi-
tion and deconvolution of images was carried out using Openlab software. For
fluorescence live-cell video microscopy and photobleaching experiments,Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 843
U2OS cells were cultured in 35 mm m-dishes with No. 1.5 bottom (Integrated
BioDiagnostics). Confocal laser scanning microscopy was performed with
a Leica TCS SP2 confocal scanning microscope. Live-cell video microscopy
and FRAP were carried out on an AppliedPrecision DeltaVision RT system
equipped with a quantifiable laser module. After photobleaching of the GFP
fluorescence with 25%–50% laser intensity, images were obtained every sec-
ond during a time frame of 3 min. Fluorescence intensities were measured and
quantified and images processed using SoftWorx software (AppliedPrecision).
For live-cell video microscopy, DIC or phase and fluorescence images were
taken every 1–5 min over a time frame of 10–48 hr.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, eight figures, and eight movies and can be found with
this article online at http://www.cell.com/cgi/content/full/132/5/832/DC1/.
ACKNOWLEDGMENTS
We thank U. Cramer for technical assistance; T. Bartke, S. Mishra, and O.
Stemmann for advice and comments on the manuscript; H. Alwan, N. Dan-
tuma, D. LeBel, J. Pera¨nen, and M. Zerial for materials. This work is supported
(to S.J.) by the Max Planck Society, Munich Center of Integrated Protein
Science, Rubicon EU Network of Excellence, and Fonds der Chemischen
Industrie.
Received: October 9, 2007
Revised: December 17, 2007
Accepted: January 8, 2008
Published: March 6, 2008
REFERENCES
Albertson, R., Riggs, B., and Sullivan, W. (2005). Membrane traffic: a driving
force in cytokinesis. Trends Cell Biol. 15, 92–101.
Alwan, H.A., and van Leeuwen, J.E. (2007). UBPY-mediated epidermal growth
factor receptor (EGFR) de-ubiquitination promotes EGFR degradation. J. Biol.
Chem. 282, 1658–1669.
Bartke, T., Pohl, C., Pyrowolakis, G., and Jentsch, S. (2004). Dual Role of
BRUCE as an Antiapoptotic IAP and a Chimeric E2/E3 Ubiquitin Ligase. Mol.
Cell 14, 801–811.
Carlton, J.G., andMartin-Serrano, J. (2007). Parallels between cytokinesis and
retroviral budding: a role for the ESCRT machinery. Science 316, 1908–1912.
Dantuma, N.P., Groothuis, T.A., Salomons, F.A., and Neefjes, J. (2006). A dy-
namic ubiquitin equilibrium couples proteasomal activity to chromatin remod-
eling. J. Cell Biol. 173, 19–26.
Eggert, U.S., Mitchison, T.J., and Field, C.M. (2006). Animal cytokinesis: from
parts list to mechanisms. Annu. Rev. Biochem. 75, 543–566.
Faty, M., Fink, M., and Barral, Y. (2002). Septins: a ring to part mother and
daughter. Curr. Genet. 41, 123–131.
Fielding, A.B., Schonteich, E., Matheson, J., Wilson, G., Yu, X., Hickson, G.R.,
Srivastava, S., Baldwin, S.A., Prekeris, R., and Gould, G.W. (2005). Rab11–
FIP3 and FIP4 interact with Arf6 and the exocyst to control membrane traffic
in cytokinesis. EMBO J. 24, 3389–3399.
Flemming, W. (1891). Neue Beitra¨gezur Kenntnis der Zelle. Arc. Mikr. Anat. 37,
685–751.
Grenfell, S.J., Trausch-Azar, J.S., Handley-Gearhart, P.M., Ciechanover, A.,
and Schwartz, A.L. (1994). Nuclear localization of the ubiquitin-activating en-
zyme, E1, is cell-cycle-dependent. Biochem. J. 300, 701–708.
Gromley, A., Jurczyk, A., Sillibourne, J., Halilovic, E., Mogensen, M., Grois-
man, I., Blomberg, M., andDoxsey, S. (2003). A novel human protein of thema-
ternal centriole is required for the final stages of cytokinesis and entry into S
phase. J. Cell Biol. 161, 535–545.844 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.Gromley, A., Yeaman, C., Rosa, J., Redick, S., Chen, C.T., Mirabelle, S., Guha,
M., Sillibourne, J., andDoxsey, S.J. (2005). Centriolin anchoring of exocyst and
SNARE complexes at the midbody is required for secretory-vesicle-mediated
abscission. Cell 123, 75–87.
Hao, Y., Sekine, K., Kawabata, A., Nakamura, H., Ishioka, T., Ohata, H., Ka-
tayama, R., Hashimoto, C., Zhang, X., Noda, T., et al. (2004). Apollon ubiquiti-
nates SMAC and caspase-9, and has an essential cytoprotection function.
Nat. Cell Biol. 6, 849–860.
Hauser, H.P., Bardroff, M., Pyrowolakis, G., and Jentsch, S. (1998). A giant
ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J. Cell Biol.
141, 1415–1422.
Kasahara, K., Nakayama, Y., Nakazato, Y., Ikeda, K., Kuga, T., and Yamagu-
chi, N. (2007). Src signaling regulates completion of abscission in cytokinesis
through ERK/MAPK activation at themidbody. J. Biol. Chem. 282, 5327–5339.
Kuriyama, R., Gustus, C., Terada, Y., Uetake, Y., and Matuliene, J. (2002).
CHO1, a mammalian kinesin-like protein, interacts with F-actin and is involved
in the terminal phase of cytokinesis. J. Cell Biol. 156, 783–790.
Li, F., Ackermann, E.J., Bennett, C.F., Rothermel, A.L., Plescia, J., Tognin, S.,
Villa, A., Marchisio, P.C., and Altieri, D.C. (1999). Pleiotropic cell-division de-
fects and apoptosis induced by interference with survivin function. Nat. Cell
Biol. 1, 461–466.
Lindon, C., and Pines, J. (2004). Ordered proteolysis in anaphase inactivates
Plk1 to contribute to proper mitotic exit in human cells. J. Cell Biol. 164,
233–241.
Liu, X., and Erikson, R.L. (2007). The nuclear localization signal of mitotic kine-
sin-like protein Mklp-1: effect on Mklp-1 function during cytokinesis. Biochem.
Biophys. Res. Commun. 353, 960–964.
Lotz, K., Pyrowolakis, G., and Jentsch, S. (2004). BRUCE, a giant E2/E3 ubiq-
uitin ligase and inhibitor of apoptosis protein of the trans-Golgi network, is re-
quired for normal placenta development and mouse survival. Mol. Cell. Biol.
24, 9339–9350.
Matuliene, J., and Kuriyama, R. (2002). Kinesin-like protein CHO1 is required
for the formation of midbody matrix and the completion of cytokinesis in mam-
malian cells. Mol. Biol. Cell 13, 1832–1845.
Morita, E., Sandrin, V., Chung, H.Y., Morham, S.G., Gygi, S.P., Rodesch, C.K.,
and Sundquist, W.I. (2007). Human ESCRT and ALIX proteins interact with pro-
teins of the midbody and function in cytokinesis. EMBO J. 26, 4215–4227.
O’Connor, D.S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin,
S., Marchisio, P.C., and Altieri, D.C. (2000). Regulation of apoptosis at cell di-
vision by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 97,
13103–13107.
Pines, J., and Lindon, C. (2005). Proteolysis: anytime, any place, anywhere?
Nat. Cell Biol. 7, 731–735.
Potapova, T.A., Daum, J.R., Pittman, B.D., Hudson, J.R., Jones, T.N., Satin-
over, D.L., Stukenberg, P.T., and Gorbsky, G.J. (2006). The reversibility of mi-
totic exit in vertebrate cells. Nature 440, 954–958.
Ren, J., Shi, M., Liu, R., Yang, Q.H., Johnson, T., Skarnes, W.C., and Du, C.
(2005). The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway
of apoptosis and is essential for mouse embryonic development. Proc. Natl.
Acad. Sci. USA 102, 565–570.
Row, P.E., Liu, H., Hayes, S., Welchman, R., Charalabous, P., Hofmann, K.,
Clague, M.J., Sanderson, C.M., and Urbe, S. (2007). The MIT domain of
UBPY constitutes a CHMP binding and endosomal localisation signal required
for efficient EGF receptor degradation. J. Biol. Chem. 282, 30929–30937.
Samuel, T., Okada, K., Hyer, M., Welsh, K., Zapata, J.M., and Reed, J.C.
(2005). cIAP1 Localizes to the nuclear compartment andmodulates the cell cy-
cle. Cancer Res. 65, 210–218.
Schmidt, K., and Nichols, B.J. (2004). A barrier to lateral diffusion in the cleav-
age furrow of dividing mammalian cells. Curr. Biol. 14, 1002–1006.
Straight, A.F., Cheung, A., Limouze, J., Chen, I., Westwood, N.J., Sellers, J.R.,
andMitchison, T.J. (2003). Dissecting temporal and spatial control of cytokine-
sis with a myosin II Inhibitor. Science 299, 1743–1747.
Sumara, I., Quadroni,M., Frei, C., Olma,M.H., Sumara, G., Ricci, R., and Peter,
M. (2007). A Cul3-based E3 ligase removes Aurora B from mitotic chromo-
somes, regulating mitotic progression and completion of cytokinesis in human
cells. Dev. Cell 12, 887–900.
Vega, I.E., and Hsu, S.C. (2001). The exocyst complex associates with micro-
tubules to mediate vesicle targeting and neurite outgrowth. J. Neurosci. 21,
3839–3848.
Verhagen, A.M., Coulson, E.J., and Vaux, D.L. (2001). Inhibitor of apoptosis
proteins and their relatives: IAPs and other BIRPs. Genome Biol. 2, re-
views3009.1–reviews3009.Wojcik, C., Paweletz, N., and Schroeter, D. (1995). Localization of proteasomal
antigens during different phases of the cell cycle in HeLa cells. Eur. J. Cell Biol.
68, 191–198.
Wu, X., Yen, L., Irwin, L., Sweeney, C., and Carraway, K.L., 3rd. (2004). Stabi-
lization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8.
Mol. Cell. Biol. 24, 7748–7757.
Yu, X., Prekeris, R., and Gould, G.W. (2007). Role of endosomal Rab GTPases
in cytokinesis. Eur. J. Cell Biol. 86, 25–35.Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 845
